JPH04295415A - Production of dentifrice - Google Patents
Production of dentifriceInfo
- Publication number
- JPH04295415A JPH04295415A JP13235791A JP13235791A JPH04295415A JP H04295415 A JPH04295415 A JP H04295415A JP 13235791 A JP13235791 A JP 13235791A JP 13235791 A JP13235791 A JP 13235791A JP H04295415 A JPH04295415 A JP H04295415A
- Authority
- JP
- Japan
- Prior art keywords
- infrared rays
- far infrared
- dentifrice
- gingivae
- emitting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000000551 dentifrice Substances 0.000 title abstract 5
- 239000000843 powder Substances 0.000 claims abstract description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000010459 dolomite Substances 0.000 claims abstract description 5
- 229910000514 dolomite Inorganic materials 0.000 claims abstract description 5
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims abstract description 4
- 239000000919 ceramic Substances 0.000 claims abstract description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052742 iron Inorganic materials 0.000 claims abstract description 3
- 239000011777 magnesium Substances 0.000 claims abstract description 3
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 3
- 239000011591 potassium Substances 0.000 claims abstract description 3
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 3
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 3
- 239000011734 sodium Substances 0.000 claims abstract description 3
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 3
- 239000010936 titanium Substances 0.000 claims abstract description 3
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 3
- 229910052604 silicate mineral Inorganic materials 0.000 claims abstract 4
- 239000000606 toothpaste Substances 0.000 claims description 13
- 229940034610 toothpaste Drugs 0.000 claims description 12
- -1 amphibolite Substances 0.000 claims description 4
- 239000010450 olivine Substances 0.000 claims description 4
- 229910052609 olivine Inorganic materials 0.000 claims description 4
- 229910052611 pyroxene Inorganic materials 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 2
- 238000005245 sintering Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 210000002741 palatine tonsil Anatomy 0.000 abstract description 5
- 206010039083 rhinitis Diseases 0.000 abstract description 3
- 208000003265 stomatitis Diseases 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- MBDHLQKZIVIDEY-UHFFFAOYSA-N Olivin Natural products COc1cc(C=C(C)/C(=O)c2c(O)cc(O)cc2O)ccc1O MBDHLQKZIVIDEY-UHFFFAOYSA-N 0.000 abstract 1
- 229910052639 augite Inorganic materials 0.000 abstract 1
- 229910052892 hornblende Inorganic materials 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- PIHTXGRVQBTVRE-KFYAXVMHSA-N olivin Chemical compound OC1=CC(O)=C2C(O)=C(C(=O)[C@H]([C@H]([C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C3)O)C3=CC2=C1 PIHTXGRVQBTVRE-KFYAXVMHSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 4
- 230000001680 brushing effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004088 microvessel Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【０００１】0001
【産業上の利用分野】この発明は遠赤外線を放射する微
粉沫を利用して、歯と歯ぐき、口内全体の健康と改善、
衛生管理を内部から細胞単位でなすことを目的とした歯
みかき剤の製造方法に関するものである。[Industrial Application Field] This invention uses fine powder that emits far infrared rays to improve the health of teeth, gums, and the entire mouth.
The present invention relates to a method for producing a toothpaste that aims to perform hygiene control from the inside on a cell-by-cell basis.
【０００２】0002
【従来の技術】従来の歯みがき剤は、歯の表面のよごれ
をかき取る、歯垢を分解する、塩、薬の効果を持つもの
、又、アルミで外側から補強するという、外側からの衛
生管理を計るものだけであった。[Prior Art] Conventional toothpastes have the effect of scraping dirt off the surface of teeth, decomposing plaque, salt, and medicine, and are also reinforced with aluminum from the outside to manage hygiene from the outside. It was only a measure of the
【０００３】0003
【発明が解決しようとする課題】（イ） 外部から侵
入しようとする細菌等の外敵に対して、外側から防ごう
とするためにキケンな薬物であるフッ素化合物を使用し
たり、必要以上に力を入れてブラッシングをしたりして
歯とか歯ぐきを痛めることが多々ある。
（ロ） 歯みがきの仕方が悪いために、悪化するのが
通例である。
（ハ） 歯並びが悪いためにブラッシングがむずかし
い場合もある。
（ニ） 歯ぐきが相当悪くなってしまった時には細胞
自体が弱いために、薬を吸収することもできず、改善が
不可能になる。
本発明は以上のような外側からの口内衛生保守に対して
、内部から細胞を分子、原子基準で改善し、口内の衛生
管理を計るものである。[Problems to be solved by the invention] (a) In order to protect against foreign enemies such as bacteria that try to invade from the outside, dangerous drugs such as fluorine compounds are used or excessive force is used. There are many cases where teeth and gums are damaged by brushing with a toothpaste. (b) It is usually worsened by improper brushing of the teeth. (c) Brushing may be difficult due to misaligned teeth. (d) When the gums are in serious condition, the cells themselves are too weak to absorb medicine, making it impossible to improve the condition. In contrast to the above-mentioned oral hygiene maintenance from the outside, the present invention aims to improve oral hygiene from the inside by improving cells on a molecular and atomic basis.
【０００４】0004
【課題を解決するための手段】（イ） 蛇紋岩、輝石
、オリビン、角閃岩、苦灰岩等の遠赤外線を放射する岩
石を微粉沫にして、熱、又は薬品による衛生処理をして
後歯みがき基剤に適当量を混入して、よくまぜ合わせる
。
（ロ） 又は、蛇紋岩、輝石、オリビン、角閃岩、苦
灰岩等遠赤外線を放射する珪酸塩化合物を構成する主成
分であるところの、アルミナ、ジルコニア、シリカ、チ
タン、カリウム、マグネシウム、ナトリウム、鉄等の酸
化物を適正比率で焼結して、人工的に遠赤外線を放射す
る微粉沫セラミックを製造する。
（ハ） この遠赤外線を放射する微粉沫を歯みがき基
剤に適当量を加えて攪拌することによって歯みがき剤を
製造する。以上の工程から成る歯みがき剤の製造方法で
ある。[Means for solving the problem] (a) Rocks that emit far infrared rays, such as serpentinite, pyroxene, olivine, amphibolite, and dolomite, are made into fine powder, which is then subjected to sanitary treatment using heat or chemicals. Mix the appropriate amount into the toothpaste base and mix well. (b) Or alumina, zirconia, silica, titanium, potassium, magnesium, and sodium, which are the main components of silicate compounds that emit far infrared rays, such as serpentine, pyroxene, olivine, amphibolite, and dolomite. By sintering oxides such as iron in appropriate proportions, we produce fine powder ceramics that artificially emit far-infrared rays. (c) A toothpaste is produced by adding an appropriate amount of this far-infrared ray-emitting fine powder to a toothpaste base and stirring. This is a method for manufacturing a toothpaste consisting of the above steps.
【０００５】[0005]
【作用】（イ） この歯みがき剤は遠赤外線を放射す
る。
（ロ） 放射される遠赤外線の量は、微粉沫の質、量
、体積、表面積、温度、時間に比例する。
（ハ） 歯みがき剤として使用した時、微粉沫セラミ
ックは口の中の熱を吸収して、副射熱として多量の遠赤
外線を放射する。
（ニ） 口の中の各細胞組織は、その遠赤外線（電磁
波）を吸収する。
（ホ） 電磁波の共振吸収現象として、各細胞組織が
活性化する。
（ヘ） それは、発熱現象と同時に微細血管が拡張し
て、血液の循環が促進されて、白血球、赤血球の活動が
活発になり、代謝活動が促進されるからである。
（ト） 殺菌、食菌、老廃物の排摂作用等が活発に行
なわれる。
（チ） 遠赤外線は、皮下４センチメートルまで浸透
するので、鼻の中にも効果が及ぶ。
（リ） 扁桃腺にも効果が及ぶ。[Effect] (a) This toothpaste emits far infrared rays. (b) The amount of far-infrared radiation emitted is proportional to the quality, quantity, volume, surface area, temperature, and time of the fine particles. (c) When used as a toothpaste, the fine powder ceramic absorbs the heat in the mouth and emits a large amount of far-infrared rays as secondary heat. (d) Each cell tissue in the mouth absorbs far-infrared rays (electromagnetic waves). (e) As a phenomenon of resonance absorption of electromagnetic waves, each cell tissue becomes activated. (F) This is because microvessels dilate at the same time as fever occurs, promoting blood circulation, increasing the activity of white blood cells and red blood cells, and promoting metabolic activity. (g) Sterilization, edible bacteria, waste excretion, etc. are actively carried out. (H) Far-infrared rays penetrate up to 4 centimeters under the skin, so they are effective even inside the nose. (li) It also has an effect on the tonsils.
【０００６】[0006]
【実施例】医学・理学博士である山崎敏子著書「遠赤外
線療法の科学」の中で下記のように述べられている。こ
の内容は医学雑誌「日本医事新報」３０２９号（昭和５
７年５月１５日号）耳鼻科医・沢田又一先生によるもの
である。
「遠赤外線の、人体に及ぼす放射線効果は、皮下深層の
温度の上昇、微細血管の拡張、血液の循環の促進、・・
・新陳代謝の強化、組織の再生能力の増加・・・。」、
「遠赤外線の特徴は、直進性、屈折性、反射性を持つ。
」、「多くの物質に吸収されて熱反応を起す。」、「医
療用として、きわめて安全である。」全ての物質は固有
の振動を有しているが、そこに同じ波長の電磁波が当れ
ば、そのエネルギーは吸収される。吸収された分だけ、
その振幅が増大し、極限に達すると一気に熱量としてエ
ネルギーを放出する。生体内の物質は夫々の波長と同じ
波長の電磁波に出会うと、共振、吸収、発熱現象をくり
返す。それが細胞、組織温度の上昇となり、血管の拡張
、血液循の促進、従って▲お▼血、老廃物の排摂運搬、
細胞と組織の活性化が行なわれる。
以上の内容が、本発明品の使用によって徐々にではある
が、確実に口内に於て展開される内容であり、結果とし
て口内が健康に保たれるように遠赤外線原理を応用した
ものである。
（イ） 本発明品を使用することにより、歯、歯ぐき
はもちろんのこと口内全体鼻、のど、扁桃腺も同時に遠
赤外線を受ける。
（ロ） 従って、歯、歯ぐきの細胞分子が活性化して
質的に向上する。さらに、
（ハ） 毛細血管の拡張により、血液の循環が良くな
って、歯垢を通じて侵入してくる細菌等外敵に対して抵
抗力が強くなる、すなわち、歯ぐきの細胞組織の活性化
と同時に、血液循環の活性によって、相乗的効果をもた
らすことになる。
（ニ） 白血球も活性化されるのでヘルペスウイルス
に対しても、効果は発揮されて、口内炎の予防にもなる
。
（ホ） 鼻炎に対しても同じように遠赤外線の作用は
及び、改善へと向う。
（ヘ） のどの荒れ等が遠赤外線の作用によって改善
される。
（ト） 扁桃腺が強化されるので、侵入してくる細菌
、ウイルス等の外敵に対して強くなるので、カゼをひき
にくくなる。
（チ） 口内の手術等によって破壊された細胞組織の
再生補修活動が活発になり痛み、化膿が無いまま早期再
生される。
（リ） 必要に応じて、この微粉沫は着色も可能であ
るが、人体に用いるに相応しい無毒無害なものが望まし
い。
（ヌ） 微粉沫は直径１ミクロンから製造可能なので
、用途、目的によって粒子のサイズを選ぶことができる
。
（ル） 微粉沫の大きさを、何通りか組み合わせるこ
とによって目的範囲も大きくなる。
（オ） 基剤は、練、粉、水状のどれでも使える。
（ワ） ブラッシングが終った後も、口の中に含むこ
とによって効果を大きくすることができる。
（カ） 製造時に薬品等を添加することもできる。
（ヨ） 薬品等を同時使用すれば、その薬品自体も遠
赤外線を受けるので活性化する、従って薬効々果も相乗
的にあらわれる。[Example] Toshiko Yamazaki, a doctor of medicine and science, writes the following in her book "The Science of Far Infrared Therapy." This content is published in issue 3029 of the medical journal "Nihon Iji Shinpo" (1932).
(May 15, 2007 issue) Written by Dr. Mataichi Sawada, an otolaryngologist. "The radiation effects of far infrared rays on the human body increase the temperature deep beneath the skin, dilate microvessels, and promote blood circulation.
・Strengthening metabolism and increasing tissue regeneration ability... ”,
"The characteristics of far infrared rays are straightness, refraction, and reflection.", "It is absorbed by many substances and causes a thermal reaction.", "It is extremely safe for medical use." All materials are It has a unique vibration, but if electromagnetic waves of the same wavelength hit it, that energy will be absorbed. As much as it is absorbed,
Its amplitude increases, and when it reaches its limit, it releases energy in the form of heat all at once. When substances within a living body encounter electromagnetic waves of the same wavelength as their respective wavelengths, they undergo resonance, absorption, and heat generation phenomena repeatedly. This increases cell and tissue temperature, dilates blood vessels, and promotes blood circulation.
Cell and tissue activation takes place. The above contents will gradually but surely develop in the mouth through the use of the product of this invention, and as a result, the far-infrared principle is applied so that the inside of the mouth can be kept healthy. . (b) By using the product of the present invention, not only the teeth and gums, but also the entire mouth, nose, throat, and tonsils receive far infrared rays at the same time. (b) Therefore, cell molecules in teeth and gums are activated and qualitatively improved. Furthermore, (c) dilation of capillaries improves blood circulation and increases resistance to foreign invaders such as bacteria that invade through dental plaque.In other words, at the same time as the activation of gum tissue, The activation of blood circulation will result in a synergistic effect. (d) White blood cells are also activated, so it is effective against herpes viruses and can also prevent stomatitis. (e) Far-infrared rays have a similar effect on rhinitis, leading to improvement. (f) Roughness of the throat is improved by the action of far infrared rays. (g) Since the tonsils are strengthened, they become stronger against foreign invaders such as bacteria and viruses, making it difficult to catch a cold. (h) Regeneration and repair activities of cells and tissues destroyed by oral surgery, etc. become active, resulting in early regeneration without pain or suppuration. (li) If necessary, this fine powder can be colored, but it is preferable that it be non-toxic and harmless and suitable for use on the human body. (N) Fine powder droplets can be manufactured from diameters as small as 1 micron, so the particle size can be selected depending on the use and purpose. (Le) By combining several sizes of fine powder droplets, the target range can be expanded. (E) The base can be kneaded, powdered, or watery. (W) Even after brushing, you can increase the effect by keeping it in your mouth. (F) It is also possible to add chemicals, etc. during manufacturing. (Y) When drugs are used at the same time, the drugs themselves receive far-infrared rays and become activated, so the medicinal effects appear synergistically.
【０００７】[0007]
【発明の効果】（イ） 歯と歯ぐきの細胞組織が強化
され、改善される。
（ロ） 歯ぐき、口内の血行が良くなる。
（ハ） のど、扁桃腺が強化されるので、カゼをひき
にくくなる。
（ニ） 鼻炎、口内炎を改善、予防できる。[Effects of the invention] (a) Cellular tissues of teeth and gums are strengthened and improved. (b) Blood circulation in the gums and mouth improves. (c) Your throat and tonsils will be strengthened, making it harder to catch a cold. (d) It can improve and prevent rhinitis and stomatitis.
Claims (2)
灰岩等、その他遠赤外線をよく放射する珪酸塩鉱物を微
粉沫状にして、歯みがき基剤によく混ぜ合わせて製造す
ることを特徴とする歯みがき剤の製造方法。[Claim 1] It is characterized in that it is manufactured by grinding silicate minerals that emit well far-infrared rays, such as serpentine, pyroxene, olivine, amphibolite, and dolomite, into a fine powder and thoroughly mixing it with a toothpaste base. A method for producing toothpaste.
灰岩等珪酸塩鉱物を構成している主成分であるところの
シリカ、チタン、ジルコニア、アルミナ、カリウム、ナ
トリウム、マグネシウム、鉄等の酸化物を適正比率で焼
結することによってなる遠赤外線を放射する微粉沫セラ
ミックを、歯みがき基剤によく混ぜ合わせて製造するこ
とを特徴とする歯みがき剤の製造方法。[Claim 2] Silica, titanium, zirconia, alumina, potassium, sodium, magnesium, iron, etc., which are the main components of silicate minerals such as serpentine, pyroxene, olivine, amphibolite, and dolomite, etc. A method for manufacturing a toothpaste, which comprises manufacturing by thoroughly mixing a finely powdered ceramic that emits far infrared rays, which is produced by sintering oxides in an appropriate ratio, with a toothpaste base.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13235791A JPH04295415A (en) | 1991-03-25 | 1991-03-25 | Production of dentifrice |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13235791A JPH04295415A (en) | 1991-03-25 | 1991-03-25 | Production of dentifrice |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04295415A true JPH04295415A (en) | 1992-10-20 |
Family
ID=15079476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13235791A Pending JPH04295415A (en) | 1991-03-25 | 1991-03-25 | Production of dentifrice |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04295415A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020071514A (en) * | 2001-03-06 | 2002-09-13 | (주)휴먼테크 | Composition of Toothpaste Using Natural Minerals |
| KR20020089799A (en) * | 2001-05-24 | 2002-11-30 | 이상환 | New olivine material |
| WO2008144949A2 (en) * | 2007-05-30 | 2008-12-04 | Nikita Gloukhov | Use of marble for cosmetic, pharmaceutical and agricultural purposes |
-
1991
- 1991-03-25 JP JP13235791A patent/JPH04295415A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020071514A (en) * | 2001-03-06 | 2002-09-13 | (주)휴먼테크 | Composition of Toothpaste Using Natural Minerals |
| KR20020089799A (en) * | 2001-05-24 | 2002-11-30 | 이상환 | New olivine material |
| WO2008144949A2 (en) * | 2007-05-30 | 2008-12-04 | Nikita Gloukhov | Use of marble for cosmetic, pharmaceutical and agricultural purposes |
| WO2008144949A3 (en) * | 2007-05-30 | 2009-05-28 | Nikita Gloukhov | Use of marble for cosmetic, pharmaceutical and agricultural purposes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sharipova | Light and laser radiation in medicine | |
| Faria Amorim et al. | Clinical study of the gingiva healing after gingivectomy and low-level laser therapy | |
| JP6095710B2 (en) | Combination of oxidizing agents, photosensitizers and wound healing agents for oral disinfection and treatment of oral diseases | |
| Shayegan et al. | The use of beta‐tricalcium phosphate, white MTA, white Portland cement and calcium hydroxide for direct pulp capping of primary pig teeth | |
| Ciaramicoli et al. | Treatment of cervical dentin hypersensitivity using neodymium: yttrium–aluminum–garnet laser. Clinical evaluation | |
| RU2353594C2 (en) | Method and composition for obtaining disperse, bioactive or absorbable biosilicates for application in treatment of oral cavity diseases | |
| Quock | Dental caries: a current understanding and implications | |
| JPH10506908A (en) | Novel use of bioactive siliceous glass and novel compositions containing bioactive siliceous glass | |
| Shayegan et al. | Nanohydroxyapatite used as a pulpotomy and direct pulp capping agent in primary pig teeth | |
| Shayegan et al. | Beta-tricalcium phosphate, white mineral trioxide aggregate, white Portland cement, ferric sulfate, and formocresol used as pulpotomy agents in primary pig teeth | |
| CN103961371B (en) | A kind of dental treatment thing with multi-efficiency and compositions thereof | |
| Fuhseth | A study of experimentally exposed and fluoride treated dental cementum in pigs | |
| Caprioglio et al. | Lasers in dental traumatology and low level laser therapy (LLLT) | |
| Tanimoto et al. | A case of desmoplastic variant of a mandibular ameloblastoma | |
| JPH04295415A (en) | Production of dentifrice | |
| Moraes et al. | The effect of low level laser therapy in different wavelengths in the treatment of oral mucositis—proposal for extra-oral implementation | |
| Chan et al. | Low-power pulsed Nd: YAG laser irradiation for pre-emptive anaesthesia: A morphological and histological study | |
| Shankland et al. | Osteocavitation lesions (Ratner bone cavities): Frequently misdiagnosed as trigeminal neuralgia—a case report | |
| KR100669358B1 (en) | Powder toothpaste containing far infrared ray emitting source | |
| Raldi et al. | Attachment of cultured fibroblasts and ultrastructural analysis of simulated cervical resorptions treated with high-power lasers and MTA | |
| Daneswari et al. | Restorative dentistry for children using a hard tissue laser–A Review | |
| KR19980040085A (en) | Far Infrared Radiation Chewing Gum | |
| Olivi et al. | Laser applications for vital pulp therapy | |
| US20090274633A1 (en) | Tooth powder containing elvan as radiation source of far infrared ray | |
| Djuraeva | Comparative evaluation of the application of calcium hydroxide and material on the basis of mineral trioxide of the bio-dent unit in the treatment of deep caries with temporary teeth with low invasive methods |